Dr Jeffrey David Pomerantz, DO is a
Family Medicine physician based in Delmont, New Jersey. Dr Jeffrey David Pomerantz is licensed to practice in New Jersey (license number 25MB07535500) and his current practice location is 4295 Rt 47, Delmont, New Jersey. He can be reached at his office (for appointments etc.) via phone at
(856) 785-8106.
NPI number for Dr Jeffrey David Pomerantz is 1376738732 and his current mailing address is 133 Parkview Rd, Stratford, New Jersey. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1376738732.
Physician's Profile
| Full Name | Dr Jeffrey David Pomerantz |
|---|
| Gender | Male |
|---|
| Speciality | Family Medicine |
|---|
| Location | 4295 Rt 47, Delmont, New Jersey |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
|---|
NPI Data:
- NPI Number: 1376738732
- Provider Enumeration Date: 09/10/2007
- Last Update Date: 09/10/2007
Medical Identifiers
Medical identifiers for Dr Jeffrey David Pomerantz such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
|---|
| 1376738732 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
|---|
| 207Q00000X | Family Medicine | 25MB07535500 (New Jersey) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jeffrey David Pomerantz is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
|---|
Dr Jeffrey David Pomerantz, DO
133 Parkview Rd,
Stratford, NJ 08084-1823
Ph: (856) 785-9296 | Dr Jeffrey David Pomerantz, DO
4295 Rt 47,
Delmont, NJ 08314
Ph: (856) 785-8106 |
Reviews and Comments